المؤلفون: Hoetelmans Rm

المصدر: Antiviral Therapy. 4:29-41

مصطلحات موضوعية: Pharmacology, Efavirenz, Nevirapine, business.industry, viruses, Stavudine, virus diseases, biochemical phenomena, metabolism, and nutrition, chemistry.chemical_compound, Zalcitabine, Infectious Diseases, chemistry, immune system diseases, Indinavir, Abacavir, Medicine, heterocyclic compounds, Pharmacology (medical), business, Didanosine, Saquinavir, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::f282966342a67244b69dafb1898cf652
https://doi.org/10.1177/135965359900403s01

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Schöller-Gyüre M, Kakuda TN, Raoof A, De Smedt G, Hoetelmans RM, Schöller-Gyüre, Monika, Kakuda, Thomas N, Raoof, Araz, De Smedt, Goedele, Hoetelmans, Richard M W

المصدر: Clinical Pharmacokinetics; 2009, Vol. 48 Issue 9, p561-574, 14p

المؤلفون: Kakuda TN; Janssen Research & Development LLC, Titusville, NJ, USA. tkakuda@its.jnj.com., Brochot A; Janssen Research & Development, Beerse, Belgium., Green B; Model Answers Pty Ltd, Brisbane, Australia., Nijs S; Janssen Infectious Diseases BVBA, Beerse, Belgium., Vis P; LAP&P Consultants BV, Leiden, The Netherlands., Opsomer M; Janssen Infectious Diseases BVBA, Beerse, Belgium., Tomaka FL; Janssen Research & Development LLC, Titusville, NJ, USA., Hoetelmans RM; Janssen Infectious Diseases BVBA, Beerse, Belgium.

المصدر: Journal of clinical pharmacology [J Clin Pharmacol] 2016 Nov; Vol. 56 (11), pp. 1395-1405.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study

بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print Cited Medium: Internet ISSN: 1552-4604 (Electronic) Linking ISSN: 00912700 NLM ISO Abbreviation: J Clin Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: HIV Infections/*blood , HIV-1/*drug effects , Pyridazines/*administration & dosage , Pyridazines/*blood , Reverse Transcriptase Inhibitors/*administration & dosage , Reverse Transcriptase Inhibitors/*blood, Adolescent ; Adult ; Child ; Drug Administration Schedule ; Female ; HIV Infections/drug therapy ; HIV Protease Inhibitors/administration & dosage ; HIV Protease Inhibitors/blood ; HIV Protease Inhibitors/pharmacokinetics ; Humans ; Male ; Nitriles ; Pyridazines/pharmacokinetics ; Pyrimidines ; Reverse Transcriptase Inhibitors/pharmacokinetics ; Treatment Outcome

المؤلفون: Kakuda TN; Janssen Research & Development, LLC, Titusville, NJ, USA tkakuda@its.jnj.com., Brochot A; Janssen Research and Development, BV, Beerse, Belgium., Tomaka FL; Janssen Research & Development, LLC, Titusville, NJ, USA., Vangeneugden T; Janssen Research and Development, BV, Beerse, Belgium., Van De Casteele T; Janssen Research and Development, BV, Beerse, Belgium., Hoetelmans RM; Janssen Research and Development, BV, Beerse, Belgium.

المصدر: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2014 Oct; Vol. 69 (10), pp. 2591-605. Date of Electronic Publication: 2014 Jun 20.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-2091 (Electronic) Linking ISSN: 03057453 NLM ISO Abbreviation: J Antimicrob Chemother Subsets: MEDLINE

مواضيع طبية MeSH: HIV Infections/*drug therapy , HIV Protease Inhibitors/*administration & dosage , HIV Protease Inhibitors/*pharmacokinetics , Sulfonamides/*administration & dosage , Sulfonamides/*pharmacokinetics, Age Factors ; Anti-HIV Agents/administration & dosage ; Anti-HIV Agents/adverse effects ; Anti-HIV Agents/pharmacokinetics ; Darunavir ; Drug Interactions ; Drug Therapy, Combination ; Female ; HIV Protease Inhibitors/adverse effects ; HIV-1 ; Humans ; Male ; Pregnancy ; Sex Factors ; Sulfonamides/adverse effects

المؤلفون: Kakuda TN; Janssen Research & Development, LLC, Titusville, NJ, USA., Sekar V; Janssen Research & Development, LLC, Titusville, NJ, USA., Lavreys L; Janssen Infectious Diseases BVBA, Beerse, Belgium., De Paepe E; Janssen Infectious Diseases BVBA, Beerse, Belgium., Stevens T; Janssen Infectious Diseases BVBA, Beerse, Belgium., Vanstockem M; Janssen Infectious Diseases BVBA, Beerse, Belgium., Vangeneugden T; Janssen Infectious Diseases BVBA, Beerse, Belgium., Hoetelmans RM; Janssen Infectious Diseases BVBA, Beerse, Belgium.

المصدر: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2014 Sep; Vol. 3 (5), pp. 346-52. Date of Electronic Publication: 2014 Feb 10.

نوع المنشور: Clinical Trial, Phase I; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2160-7648 (Electronic) Linking ISSN: 2160763X NLM ISO Abbreviation: Clin Pharmacol Drug Dev Subsets: MEDLINE

مواضيع طبية MeSH: Food-Drug Interactions*, Darunavir/*administration & dosage , Darunavir/*pharmacokinetics , HIV Protease Inhibitors/*administration & dosage , HIV Protease Inhibitors/*pharmacokinetics , Ritonavir/*administration & dosage, Administration, Oral ; Adult ; Area Under Curve ; Biological Availability ; Cross-Over Studies ; Darunavir/adverse effects ; Darunavir/blood ; Fasting/blood ; Female ; HIV Protease Inhibitors/adverse effects ; HIV Protease Inhibitors/blood ; Healthy Volunteers ; Humans ; Male ; Metabolic Clearance Rate ; Middle Aged ; Netherlands ; Pharmaceutical Solutions ; Postprandial Period ; Tablets ; Young Adult

المؤلفون: van Heeswijk RP; Janssen Infectious Diseases BVBA, Beerse, Belgium rvheesw1@its.jnj.com., Dannemann B; Janssen Research & Development, LLC, Titusville, NJ, USA., Hoetelmans RM; Janssen Infectious Diseases BVBA, Beerse, Belgium.

المصدر: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2014 Sep; Vol. 69 (9), pp. 2310-8. Date of Electronic Publication: 2014 May 23.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-2091 (Electronic) Linking ISSN: 03057453 NLM ISO Abbreviation: J Antimicrob Chemother Subsets: MEDLINE

مواضيع طبية MeSH: Drug Interactions*, Antitubercular Agents/*pharmacokinetics , Antitubercular Agents/*pharmacology , Diarylquinolines/*pharmacokinetics , Diarylquinolines/*pharmacology, Antifungal Agents/pharmacology ; Antiviral Agents/pharmacology ; Clinical Trials, Phase I as Topic ; Clinical Trials, Phase II as Topic ; Humans ; Tuberculosis, Multidrug-Resistant/drug therapy

المؤلفون: Kakuda TN; Janssen Research & Development, LLC, Titusville, NJ, USA, Janssen Research & Development, and Janssen Infectious Diseases BVBA, Beerse, Belgium., Leopold L, Timmers M, Van De Casteele T, Hillewaert V, Tomaka FL, Hoetelmans RM

المصدر: International journal of clinical pharmacology and therapeutics [Int J Clin Pharmacol Ther] 2014 Sep; Vol. 52 (9), pp. 805-16.

نوع المنشور: Clinical Trial, Phase I; Comparative Study; Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Dustri-Verlag Dr. K. Feistle Country of Publication: Germany NLM ID: 9423309 Publication Model: Print Cited Medium: Print ISSN: 0946-1965 (Print) Linking ISSN: 09461965 NLM ISO Abbreviation: Int J Clin Pharmacol Ther Subsets: MEDLINE

مواضيع طبية MeSH: Anti-HIV Agents/*administration & dosage , Anti-HIV Agents/*pharmacokinetics , Sulfonamides/*administration & dosage , Sulfonamides/*pharmacokinetics, Administration, Oral ; Adolescent ; Adult ; Anti-HIV Agents/blood ; Area Under Curve ; Biological Availability ; Chemistry, Pharmaceutical ; Cross-Over Studies ; Darunavir ; Drug Administration Schedule ; Drug Therapy, Combination ; Fasting/blood ; Female ; Half-Life ; Healthy Volunteers ; Humans ; Least-Squares Analysis ; Male ; Metabolic Clearance Rate ; Middle Aged ; Postprandial Period ; Ritonavir/administration & dosage ; Sulfonamides/blood ; Tablets ; Therapeutic Equivalency ; Young Adult